Other GLP-1 agonists include dulaglutide (Trulicity), liraglutide (Saxenda and Victoza), exenatide (Bydueron and Byetta), semaglutide (Rybelsus), and tirzepatide (Mounjaro)
Measurements of energy expenditure and locomotor activity HFD-induced obese C57BL/6J male mice were placed in individual small acryl calorimeter chambers with free access to HFD and water, and respiratory gas (O 2 and CO 2 ) were measured every 5 min for each individual mouse by indirect calorimetry system connected to mass spectrometer (Arco2000, ArcoSystem, Chiba, Japan)
GLP-1 is a medication used for weight loss, to treat type 2 diabetes and to reduce the risk of major adverse cardiovascular events
In 8 years, the market is projected to reach $470B
(9) ET dataset 100 : 45 patients with ET and 45 HC individuals from the PIPD dataset